Scientists have
claimed to finish mapping of genetic mutations in breast cancer. Genetic
mutation is an important process in Cancer. Mapping of such process would give
better understanding to develop more effective treatment. This study is likely
going to change the current course of treatment.
The study has
revealed some startling facts. One such finding is that genetic of one of the
deadliest types of breast cancer is nearer to ovarian cancer than other breast
cancer. Findings of the study have been published on Journal Nature.
The discovery is
expected to benefit breast cancer patients very soon, said Dr Matthew Ellis. Dr
Ellis, a co-leader of the study, is from Washington University School of
Medicine. Triple negative breast cancer treatment would be better with less
toxic chemotherapy.
The study also
indicates sea-change in how differently cancer is being seen. Now it’s not just
where tumor originated but understanding cancer cells at molecular level.
The study is the part
of research project called Cancer Genome Atlas. The project is supervised by Dr
Brad Ozenberger at National Institutes of Health. The project would provide
drug companies a clear direction on which genetic mutation should be the target
of their new drug.
